EHealth Begin Period Cash Flow vs Price Cash Flow Ratio Analysis
EHTH Stock | USD 5.00 0.05 1.01% |
EHealth financial indicator trend analysis is much more than just examining eHealth latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether eHealth is a good investment. Please check the relationship between EHealth Begin Period Cash Flow and its Price Cash Flow Ratio accounts. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in eHealth. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. For more detail on how to invest in EHealth Stock please use our How to Invest in EHealth guide.
Begin Period Cash Flow vs Price Cash Flow Ratio
Begin Period Cash Flow vs Price Cash Flow Ratio Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of eHealth Begin Period Cash Flow account and Price Cash Flow Ratio. At this time, the significance of the direction appears to have fragmental relationship.
The correlation between EHealth's Begin Period Cash Flow and Price Cash Flow Ratio is 0.47. Overlapping area represents the amount of variation of Begin Period Cash Flow that can explain the historical movement of Price Cash Flow Ratio in the same time period over historical financial statements of eHealth, assuming nothing else is changed. The correlation between historical values of EHealth's Begin Period Cash Flow and Price Cash Flow Ratio is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Begin Period Cash Flow of eHealth are associated (or correlated) with its Price Cash Flow Ratio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Price Cash Flow Ratio has no effect on the direction of Begin Period Cash Flow i.e., EHealth's Begin Period Cash Flow and Price Cash Flow Ratio go up and down completely randomly.
Correlation Coefficient | 0.47 |
Relationship Direction | Positive |
Relationship Strength | Weak |
Begin Period Cash Flow
The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.Price Cash Flow Ratio
Most indicators from EHealth's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into eHealth current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in eHealth. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. For more detail on how to invest in EHealth Stock please use our How to Invest in EHealth guide.As of now, EHealth's Tax Provision is decreasing as compared to previous years. The EHealth's current Sales General And Administrative To Revenue is estimated to increase to 0.35, while Selling General Administrative is projected to decrease to under 46.8 M.
2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 536.2M | 403.7M | 451.1M | 473.7M | Total Revenue | 538.2M | 405.4M | 452.9M | 475.5M |
EHealth fundamental ratios Correlations
Click cells to compare fundamentals
EHealth Account Relationship Matchups
High Positive Relationship
High Negative Relationship
EHealth fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 741.6M | 1.0B | 1.1B | 1.1B | 1.1B | 1.2B | |
Total Stockholder Equity | 527.2M | 837.6M | 982.1M | 914.2M | 904.1M | 949.3M | |
Retained Earnings | 271.9M | 316.2M | 193.2M | 73.8M | 7.3M | 6.9M | |
Other Assets | 421.3M | 603.1M | 690.3M | 648.2M | 202.9M | 147.4M | |
Common Stock Shares Outstanding | 24.5M | 27.0M | 26.8M | 27.4M | 28.0M | 21.4M | |
Liabilities And Stockholders Equity | 741.6M | 1.0B | 1.1B | 1.1B | 1.1B | 1.2B | |
Other Stockholder Equity | (16.7M) | 521.0M | 555.9M | 577.2M | 598.8M | 628.7M | |
Total Liab | 214.5M | 202.5M | 167.2M | 198.4M | 209.3M | 219.7M | |
Other Current Liab | 81.1M | 36.8M | 50.6M | 40.9M | 57.2M | 60.1M | |
Total Current Liabilities | 113.0M | 84.4M | 75.5M | 60.6M | 78.5M | 40.2M | |
Other Liab | 67.2M | 76.7M | 55.9M | 37.5M | 43.1M | 22.7M | |
Property Plant And Equipment Net | 47.1M | 57.2M | 49.5M | 32.0M | 27.6M | 16.2M | |
Current Deferred Revenue | 2.6M | 308K | 52.8M | 32.4M | (127K) | (120.7K) | |
Net Debt | 15.6M | 2.8M | (40.6M) | (37.6M) | (12.6M) | (13.2M) | |
Accounts Payable | 24.6M | 36.9M | 13.8M | 6.7M | 7.2M | 7.6M | |
Cash | 23.5M | 43.8M | 81.9M | 144.4M | 115.7M | 85.4M | |
Non Current Assets Total | 533.5M | 709.0M | 741.7M | 711.5M | 731.0M | 767.5M | |
Non Currrent Assets Other | 21.4M | 603.1M | 690.3M | 612.6M | 679.8M | 713.8M | |
Cash And Short Term Investments | 23.5M | 93.4M | 123.2M | 144.4M | 121.7M | 97.3M | |
Net Receivables | 176.9M | 221.0M | 260.6M | 245.4M | 922.2M | 968.3M | |
Common Stock Total Equity | 35K | 38K | 39K | 40K | 46K | 29.8K | |
Non Current Liabilities Total | 101.5M | 118.1M | 91.7M | 137.8M | 130.7M | 137.3M | |
Other Current Assets | 2.4M | 16.7M | 23.8M | 11.3M | 8.6M | 6.1M | |
Property Plant And Equipment Gross | 47.1M | 57.2M | 49.5M | 32.0M | 38.8M | 40.7M | |
Total Current Assets | 208.1M | 331.0M | 407.6M | 401.1M | 382.4M | 401.5M | |
Accumulated Other Comprehensive Income | 116K | 350K | 390K | (73K) | (82K) | (77.9K) | |
Short Term Debt | 4.8M | 10.4M | 11.1M | 13.0M | 14.1M | 11.2M | |
Intangible Assets | 10.1M | 8.6M | 1.9M | 31.3M | 23.6M | 24.8M | |
Common Stock | 35K | 38K | 39K | 40K | 41K | 30.5K | |
Property Plant Equipment | 10.5M | 14.6M | 49.5M | 5.5M | 6.3M | 9.4M | |
Short Long Term Debt Total | 39.1M | 46.6M | 41.4M | 106.8M | 103.2M | 53.8M | |
Inventory | 5.5M | 16.1M | 22.9M | 1.0 | 0.9 | 0.86 | |
Net Tangible Assets | 511.2M | 830.1M | 747.6M | 914.2M | 1.1B | 1.1B | |
Retained Earnings Total Equity | 271.9M | 316.2M | 193.2M | 73.8M | 84.9M | 101.3M | |
Capital Surpluse | 455.2M | 721.0M | 755.9M | 777.2M | 893.8M | 472.6M | |
Deferred Long Term Liab | 64.1M | 72.3M | 50.8M | 32.4M | 37.2M | 26.0M |
Currently Active Assets on Macroaxis
When determining whether eHealth offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of EHealth's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Ehealth Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Ehealth Stock:Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in eHealth. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. For more detail on how to invest in EHealth Stock please use our How to Invest in EHealth guide.You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Is Insurance Brokers space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of EHealth. If investors know EHealth will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about EHealth listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 2.108 | Earnings Share (2.62) | Revenue Per Share 16.016 | Quarterly Revenue Growth (0.1) | Return On Assets (0.01) |
The market value of eHealth is measured differently than its book value, which is the value of EHealth that is recorded on the company's balance sheet. Investors also form their own opinion of EHealth's value that differs from its market value or its book value, called intrinsic value, which is EHealth's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because EHealth's market value can be influenced by many factors that don't directly affect EHealth's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between EHealth's value and its price as these two are different measures arrived at by different means. Investors typically determine if EHealth is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, EHealth's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.